A new study demonstrates a breakthrough in Alzheimer's disease (AD) treatment using lipid nanoparticles (LNPs) to deliver small interfering RNA (siRNA) to the brain's microglia. This approach effectively suppresses a protein linked to Alzheimer's-related inflammation.
Novel Nanoparticle Delivery System Targets Alzheimer's Inflammation
Neuroscience News - 12 Dec 2023 17:35
A new study demonstrates a breakthrough in Alzheimer's disease (AD) treatment using lipid nanoparticles (LNPs) to deliver small interfering RNA (siRNA) to the brain's microglia. This approach effectively suppresses a protein linked to Alzheimer's-related inflammation.
Share this Article
Recommended